FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Maintains Hold Opinion On Adss Of Infosys Limited

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

We reduce our 12-month target price to USD13 from USD14.00 by rolling forward our valuation to FY 28 EPS and applying a P/E of 14.4x. This represents a 1.25 standard deviation discount to its 10-year average of 21.6x. The lower multiple reflects constrained earnings visibility due to AI-led efficiency, cautious discretionary spending, and limited visibility on deal conversion timing. We maintain our FY 27 revenue forecast at USD20.9B and introduce our FY 28 revenue estimate of USD21.7B, implying gradual growth as pipeline conversion improves but remains measured. We also maintain our FY 27 EPS view at USD0.85 and introduce FY 28 EPS of USD0.88, reflecting stable margins with modest revenue growth. We remain cautious as cyclical segments continue to weigh on growth, with weakness in manufacturing and telecom offsetting strength in core enterprise verticals. We believe earnings will improve only when deal ramp-ups become more consistent and client spending recovers.

Related Articles

Australia

Nasdaq Faces Upside as AI Fears Fade and Investors Feel Confident About Growth, UBS Says

Nasdaq (NDAQ) continues to execute well, and the stock could move higher as concerns around artificial intelligence fade and investors feel more confident in its growth trajectory, UBS Securities said in a report Friday, keeping the stock as a top pick.UBS said it remains bullish on Nasdaq following Q1 results, given strong underlying growth across all segments, with a notable acceleration in FinTech organic annual recurring revenue growth of 16.3% year-over-year.Growth in the FinTech segment progressed due to strong performance in the Capital Markets Technology business, which saw 20.5% revenue growth and added $84 million in Q1 ARR, according to the note.In Capital Access Platforms, an expected recovery in capital markets should be constructive, while the introduction of 23/5 trading is seen as a tailwind for market data, the firm noted. UBS expects near-term revenue acceleration for the Index business, with revenue growth of 17.2% forecasted for Q2.The brokerage said it adjusted its fiscal 2026 EPS estimate to $3.89 from $3.90 and fiscal 2027 EPS forecast to $4.39 from $4.37.UBS maintained a buy rating on Nasdaq with a price target of $120.Price: $89.65, Change: $+2.60, Percent Change: +2.99%

$NDAQ
Australia

Sanofi Prices $2.7 Billion in Bonds in Three-Part Offering

Sanofi (SNY) priced its 2.3 billion euro ($2.7 billion) offering of notes under its Euro Medium Term Note program.The deal includes 1 billion euros in notes due May 2029 with a 3% coupon, 650 million euros in notes due May 2033 at 3.375%, and 650 million euros in notes due May 2037 at 3.75%, the company said Friday in a statement.Sanofi plans to use the net proceeds for general corporate purposes.Price: $46.95, Change: $-0.59, Percent Change: -1.23%

$SNY
Australia

Comcast Likely to See Weaker Q2 Connectivity Trends, UBS Says

Comcast (CMCSA) is expected to see worsening connectivity trends in Q2, even as its Q1 results came in better than expected, according to a UBS note on Friday.UBS said it expects connectivity declines to deepen in Q2, citing higher broadband average revenue per user declines, tougher business comparisons and fading foreign exchange tailwinds.The brokerage noted that while Q1 showed early signs of progress in Comcast's strategic pivot, supported by lower broadband subscriber losses and more stable operating trends, the near-term outlook remains challenging.UBS added that management remains open to strategic options, including partnerships, while continuing to focus on executing its standalone strategy.The firm maintained a neutral rating on the stock with a $32 price target.Price: $28.05, Change: $-3.60, Percent Change: -11.36%

$CMCSA